British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm’s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray’s deal with Quebec-based Sandoz AG is an extension of a letter of intent the companies signed in March to produce co-branded, nonsmokable and noncombustible […]
Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary
Comments are closed, but trackbacks and pingbacks are open.